Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. for allegedly making false and misleading statements regarding its financial guidance and business operations during the Class Period from February 26, 2025, to August 4, 2025 [3][7]. Allegation Details - The lawsuit claims that Agilon's management issued guidance for 2025 that was unrealistic given known industry challenges [3]. - It is alleged that the company overstated the positive financial impact from strategic actions taken to mitigate risks [3]. - As a result, statements made by the defendants regarding Agilon's business and prospects were materially false and misleading [3]. Next Steps - Investors who acquired Agilon shares and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is March 2, 2026 [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to alleged violations of federal securities laws, encouraging affected investors to contact them for legal options [2][4]. Group 1: Legal Investigation - The law firm is reminding investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against agilon health [2]. - The complaint alleges that agilon health and its executives made false or misleading statements regarding the company's financial guidance for 2025, which they knew was unattainable due to industry challenges [4]. Group 2: Financial Impact - On August 4, 2025, agilon health announced the suspension of its full-year 2025 financial guidance, leading to a significant stock price drop of 51.5% on August 5, 2025 [5]. - The complaint claims that the defendants overstated the financial benefits from strategic actions taken to mitigate risks, resulting in materially false statements about the company's business and prospects [4]. Group 3: Firm Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its establishment in 1995 and has offices in New York, Pennsylvania, California, and Georgia [3].

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased agilon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fe ...

Core Viewpoint - The complaint against agilon health alleges that the company and its executives violated federal securities laws by making false or misleading statements and failing to disclose significant risks related to their 2025 guidance and financial impacts from strategic actions taken to reduce risk [2]. Group 1 - The complaint claims that the defendants recklessly issued guidance for 2025, which they knew or should have known was unattainable due to material industry headwinds [2]. - It is alleged that the defendants materially overstated the immediate positive financial impact from strategic actions taken by agilon to mitigate risk [2]. - As a result of these actions, the statements made by the defendants regarding agilon's business, operations, and prospects were materially false and misleading at all times [2]. Group 2 - The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class, who directs and oversees the litigation on behalf of the putative class [3]. - Any member of the putative class has the option to move the Court to serve as lead plaintiff or may choose to remain an absent class member without affecting their ability to share in any recovery [3]. Group 3 - Faruqi & Faruqi, LLP encourages individuals with information regarding agilon health's conduct to contact the firm, including whistleblowers and former employees [4].

New York, New York--(Newsfile Corp. - February 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased agilon securities during the Class Period you may be entitled to compensation without payment of any out ...

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of agilon health, inc. (NYSE: AGL). Shareholders who purchased shares of AGL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/agilon-health-inc-loss-submission-form/?id=183338&from=3 CLASS PERIOD: February 26 ...

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/agilon ...

New York, New York--(Newsfile Corp. - February 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased agilon securities during the Class Period you may be entitled to compensation without payment of any out ...

Boston, Massachusetts--(Newsfile Corp. - February 4, 2026) - Block & Leviton reminds investors that a securities fraud lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain of its executives. Investors who have lost money in their agilon health investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/agl.What is this all about?Shares of agilon health, Inc. (NYSE: AGL) fell more than 25% in after-h ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - Fe ...